Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002667 · ClinicalTrials.gov registry record · NA

Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer

A NA study of Lung Cancer, sponsored by Eastern Cooperative Oncology Group.

Completed
Registry status
NA
Development phase
1,100
Enrollment target
5
Study locations

NCT00002667: Completed NA study of Lung Cancer, sponsored by Eastern Cooperative Oncology Group.

NCT00002667 is a NA study of Lung Cancer that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 1,100 participants, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (18% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002667, a NA study of Lung Cancer, has completed, sponsored by Eastern Cooperative Oncology Group.

COMPLETED
Registry status
NA
Development phase
1,100 participants
Enrollment target
5
Study locations

Study Summary

RATIONALE: Using new methods to examine sputum samples for the presence of cancer cells may detect lung cancer earlier. PURPOSE: Screening trial to study the effectiveness of new methods of examining sputum samples to detect second primary lung cancer in patients with resected stage I non-small cell lung cancer.

Conditions Studied

Lung Cancer

Interventions

  • OTHER cytology specimen collection procedure
  • PROCEDURE study of high risk factors
  • OTHER immunoenzyme technique

Study Locations (5)

Florida

  • H. Lee Moffitt Cancer Center and Research Institute - Tampa

Iowa

  • CCOP - Iowa Oncology Research Association - Des Moines

New Jersey

  • CCOP - Northern New Jersey - Hackensack

Ohio

  • Ireland Cancer Center - Cleveland

Pennsylvania

  • Allegheny University Hospitals- Hahnemann - Philadelphia

Trial Details

FieldValue
Enrollment Target 1,100 participants
Start Date 1995-10-10
Est. Completion 2004-10-01
Phase NA

Sponsor

Eastern Cooperative Oncology Group

141 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002667

The ClinicalTrials.gov registry entry for NCT00002667 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (18% higher). The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 3 interventions - of which cytology specimen collection procedure is the first listed.

NCT00002667 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Florida, Iowa, New Jersey.

Frequently Asked Questions

What is clinical trial NCT00002667 about?

NCT00002667 is a clinical study titled "Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer". RATIONALE: Using new methods to examine sputum samples for the presence of cancer cells may detect lung cancer earlier. PURPOSE: Screening trial to study the effectiveness of new methods of examining sputum samples to detect second primary lung cancer in patients with resected stage I non-small cel...

What is the current status of trial NCT00002667?

This trial is currently completed. It is a NA study. The enrollment target is 1,100 participants. The study started on 1995-10-10. Estimated completion is 2004-10-01.

What conditions does trial NCT00002667 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT00002667?

The interventions under investigation include: cytology specimen collection procedure (OTHER), study of high risk factors (PROCEDURE), immunoenzyme technique (OTHER).

Who is sponsoring clinical trial NCT00002667?

This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002667 being conducted?

This trial has 5 study locations across Florida, Iowa, New Jersey, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.